NDMA caused malignant tumor growth in several organs, in multiple species, via numerous routes of exposure (oral, inhalation, subcutaneous (under the skin), injections), with dose-response relationships appearing in several studies. IARC placed the chemical in the “Group 2A” category, meaning substances that are “probably carcinogenic to humans.” The agency found that NDMA is “carcinogenic in all animal species tested” and noted that the metabolism of NDMA by humans and animals is similar. The International Agency for Cancer Research (IARC), the most recognized cancer research institution in the world, studied over 200 research papers on NDMA and the NDMA cancer risk. Studies show that NDMA exposure as little as 179 ng per 100 grams per day is associated with elevated cancer risks. The FDA’s acceptable daily intake of NDMA is 96 nanograms (ng), or 96 billionths of a gram. NDMA is carcinogenic even in minimal doses. Humans can be exposed to NDMA in relatively small amounts through various products, including tobacco, foods (cured meat, fish, cheese, beer), shampoos, cleansers, and pesticides. It can also be produced as a byproduct of manufacturing processes. NDMA was once used to make rocket fuel, but today is made only for research purposes. N-Nitrosodimethylamine (NDMA) is a water-soluble organic (containing the element carbon) chemical and appears as a yellow liquid with little or no obvious taste or odor. Is your law firm looking to refer Zantac cases? Please visit our Zantac Case Referral page for more information. On April 1, 2020, the FDA requested a market withdrawal for Zantac ranitidine drugs, stating that NDMA in some ranitidine medications “increases over time and when stored at higher than room temperatures and may result in consumer exposure to unacceptable levels…” Zantac lawsuits began after the FDA confirmed that ranitidine contains NDMA. Food and Drug Administration’s (FDA) daily acceptable intake limit of 96 ng. Independent laboratory testing found that one ranitidine 150 mg tablet produced 304,500 nanograms (ng) of a cancer-causing substance called N-Nitrosodimethylamine (NDMA), an amount that greatly exceeds the U.S. People who developed cancer after taking Zantac (generic: ranitidine) may choose to file a Zantac lawsuit against the drug manufacturers to recover financial compensation for past, present, and future medical bills, lost wages, and other damages.Ĭheck to see if you are eligible to pursue a Zantac lawsuit by filling out this confidential case evaluation form.
0 Comments
Leave a Reply. |
Details
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |